The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery


Mar 11, 2019


For over more than two hours, the first edition of the BioInternational Seminars 2019, hosted by the Biotechnology Business Institute, was a success in terms of participation and interaction between the panelist and the audience. “This type of interaction helps young scientific profiles to understand the sector and have a vision in the horizons of drug discovery in lifesciences”, - ensures Juan R. Garcia, Chairman at the Biotechnology Business Institute.

In this first edition of the year, three international professionals with different backgrounds participated as panelists over the evening. Lubor Gaal, Vice-President of Business Development in Europe for Locust Walk, a global lifescience firm helping biopharma and medtech clients with financing and business development transactions; Jordi Naval, Chief Executive Officer  of Biocat, the Catalan BioRegion Foundation, and also Co-founder of Aelix Therapeutics; and François Riva, Director of Business development at MedSir, a company focused on the innovative design and management os strategic clinical trials for, among others, immuno-oncology, one of the most promising therapeutic area for new treatments in oncology nowadays.

Different topics were discussed regarding drug developments and interactions in the global sector and one of the main conclusions was, that the ecosystem in Barcelona is deeply growing and the development of young professionals with an international view and vision is crucial to support the future ecosystem. Different points of view from different backgrounds such the industry, financials, biotechnology companies, governments and innovation clusters, did conclude that the versatility of a scientific profile, with a global understanding of the sector is definitely an enormous add value for their professional development.

Press Release

Gallery

Next Edition of the BioInternational Seminars 2019, 4th of April at the Scientific Park of Barcelona

Latest news

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

The Biotechnology Business Institute inaugurated the fifth edition of the master’s programs with the consolidation of its innovative educational model, Discover&Transfer

After the success of the first edition of the Discover&Transfer program, the new students of the Biotechnology Business Institute will develop new patents from the main research institutions of Barcelona.

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

BIOSPAIN 2018 consolidates the congress as the 5th world biotechnology event

The ninth edition of the BIOSPAIN International Biotechnology Meeting, which ASEBIO organizes every two years, brought together more than 600 companies from 30 countries in the city of Seville.

Filter by category